Genotype frequencies of 50 polymorphisms for 241 Japanese non-cancer patients

Journal of Epidemiology

Volumn 12, Issue 3, 2002, Pages 229-236

  Hamajima, Nobuyuki ^a   Saito, Toshiko ^a   Matsuo, Keitaro ^a,b   Suzuki, Takashi ^a   Nakamura, Tsuneya ^a   Matsuura, Akio ^a   Okuma, Katashi ^a   Tajima, Kazuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Genotype frequencies; PCR CTPP; Polymorphisms

Indexed keywords

ALLELE; ARTICLE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HOSPITALIZATION; HUMAN; JAPAN; POLYMERASE CHAIN REACTION; POPULATION GENETICS;

ALLELES; GENETICS, POPULATION; GENOTYPE; HOSPITALIZATION; HUMANS; JAPAN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0036559414     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.12.229     Document Type: Article

References (45)

1. Kamizono S, Hiromatsu Y, Seki N et al. A polymorphism of the 5′ flanking region of tumour necrosis factor a gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf), 2000; 52: 759-764.
2. Chouchane L, Ahmed SB, Baccouche S, Remadi S. Polymorphism in the tumor necrosis factor-α promoter region and in the heat shock protein 70 genes associated with malignant tumors. Cancer, 1997; 80: 1489-1496.
3. Matsuo K, Hamajima N, Shinoda M et al. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis, 2001; 22: 913-916.
4. Takezaki T, Hamajima N, Matsuo K et al. Association of polymorphisms in the beta-2 and beta-3 adrenoceptor genes with risk of colorectral cancer in Japanese. Int J Clin Oncol, 2001; 6: 117-122.
5. Hamajima N, Matsuo K, Tajima K et al. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int J Clin Oncol, 2001; 6: 13-18.
6. Hamajima N, Takezaki T, Matsuo K et al. Genotype frequencies of cyclooxygenase 2 (COX2) rare polymorphisms in Japanese with and without colorectal cancer. Asian Pacific J Cancer Prev, 2001; 2: 57-62.
7. Hamajima N, Iwata H, Obata Y et al. No association of the 5′ promoter region polymorphism of CYP17 with breast cancer risk in Japan. Jpn J Cancer Res, 2000; 91: 880-885.
8. Hamajima N, Matsuo K, Saito T et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res, 2001; 92: 383-389.
9. Kumimoto H, Hamajima N, Nishizawa K et al. Different susceptibility of each L-myc genotype to esophageal cancer risk factors. Jpn J Cancer Res, 2001; 92: 735-739.
10. Matsuo K, Hamajima N, Shinoda M et al. Possible risk reduction in esophageal cancer associated with MPO -463 A allele. J Epidemiol, 2001; 11: 109-114.
11. Matsuo K, Suzuki R, Hamajima N et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood, 2001; 97: 3205-3209.
12. Ikehara Y, Nishihara S, Yasutomi H et al. Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol Biomarkers Prev, 2001; 10: 971-977.
13. Hamajima N, Matsuo K, Suzuki T et al. No association of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett, 2002; 181: 81-85.
14. Hamajima N, Matsuo K, Iwata H et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of eight cancers for Japanese. Int J Clin Oncol. (in press).
15. Hamajima N, Katsuda N, Matsuo K et al. Smoking habit and Interleukin 1B C-31T polymorphism. J Epidemiol, 2001; 11: 120-125.
16. Hamajima N, Saito T, Matsuo K et al. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res, 2000; 91: 865-868.
17. Bailly S, di Giovine FS, Blakemore AI, Duff GW. Genetic polymorphism of human interleukin-1α. Eur J Immunol, 1993; 23: 1240-1245.
18. Yamada Y, Watanabe M, Murata M et al. Impact of genetic polymorphisms of 17-hydroxylase cytochrome p-450 (CYP17) and steroid 5α-reductase type II (SRD5A2) genes of prostate-cancer risk among the Japanese population. Int J Cancer, 2001; 92: 683-686.
19. Vineis P, Malats N, Lang M et al. Metabolic polymorphisms and susceptibility to cancer. IARC Scientific Publications No. 148. International Agency for Research on Cancer, Lyon, 1999.
20. Dunning AM, Healey CS, Pharoah PD et al. A systematic review of genetic, polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 1999; 8: 843-854.
21. Bartsch H, Nair U, Risch A et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancer. Cancer Epidemiol Biomarkers Prev, 2000; 9: 3-28.
22. Takeshita T, Morimoto K, Mao XQ, Hashimoto T, Furuyama J. Phenotypic differences in low Km aldehyde dehydrogenase in Japanese workers. Lancet, 1993; 341: 837-838.
23. Sato R. The role of β2-adrenoceptor gene polymorphisms in asthma. Hokkaido Igaku Zasshi, 2000; 75: 81-94, (in Japanese)
24. Endo K, Yanagi H, Hirano C et al. Association of Trp64Arg polymorphism of the β3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity. Int J Obes, 2000; 24: 443-449.
25. Ohmori O, Shinkai T, Kojima H, Terao T, Suzuki T, Mita T, Abe K. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett, 1998; 243: 109-112.
26. Yanai H, Chiba H, Morimoto M et al. Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol. Am J Med Genet, 2000; 93: 299-304.
27. Miyamoto M, Umetsu Y, Dosaka-Akita H et al. CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem Biophys Res Commun, 1999; 261: 658-660.
28. Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S. Genetic polymorphism in CYP17 and breast cancer risk in Japanese women. Eur J Cancer, 2000; 36: 2375-2379.
29. Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S. Breast cancer risk associated with polymorphism in CYP19 in Japanese women. Int J Cancer, 2000; 89: 325-328.
30. Nishimura M, Mizuta I, Mizuta E et al. Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson's disease. Neurosci Lett, 2000; 284: 73-76.
31. Ishii T, Matsuse T, Teramoto S et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med, 2000; 94: 847-851.
32. Narimatsu H, Iwasaki H, Nakayama F et al. Leim and Secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients. Cancer Res, 1998; 58: 512-518.
33. Shibuta K, Inoue H, Sato K et al. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer. Jpn J Cancer Res, 2000; 91: 199-203.
34. Morita H, Taguchi J, Kurihara H et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation, 1997; 95: 2032-2036.
35. Kunugi H, Ishida S, Kato T et al. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry, 1999; 4: 393-395.
36. Naoe T, Takeyama K, Yokozawa T et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res, 2000; 6: 4091-4095.
37. Sugimura H, Kohno T, Wakai K et al. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 1999; 8: 669-674.
38. Minaguchi T, Kanamori Y, Matsushima M et al. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res, 1998; 58: 4585-4586.
39. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29 → C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation, 2000; 101: 2783-2787.
40. Shimura T, Hagihara M, Takebe K et al. The study of tumor necrosis factor beta gene polymorphism in lung cancer patients. Cancer, 1994; 73: 1184-1188.
41. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 2000; 404: 398-402.
42. Corrections: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature, 2001; 412: 99.
43. Moffatt MF, Cookson WO. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet, 1997; 6: 551-554.
44. Hamajima N. PCR-CTPP: a new genotyping technique in the era of genetic epidemiology. Expert Rev Mol Diagn, 2001; 1: 119-123.
45. Hamajima N, Saito T, Matsuo K, Tajima K. Competitive amplification and unspecific amplification in polymerase chain reaction with confronting two-pair primers. J Mol Diagn, 2002; 4: 103-107.